Intravenous Single-Dose Toxicity of Redaporfin-Based Photodynamic Therapy in Rodents-Reference-Cited by-同舟云学术

Intravenous Single-Dose Toxicity of Redaporfin-Based Photodynamic Therapy in Rodents

Published:2015-12-08 Issue:12 Volume:16 Page:29236-29249
ISSN:1422-0067
Container-title:International Journal of Molecular Sciences
language:en
Short-container-title:IJMS

Author:

Rocha Luis,Schaberle Fábio^ORCID,Dąbrowski Janusz,Simões Sérgio,Arnaut Luis

Publisher

MDPI AG

Subject

Inorganic Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Computer Science Applications,Spectroscopy,Molecular Biology,General Medicine,Catalysis

Link

http://www.mdpi.com/1422-0067/16/12/26162/pdf

Reference29 articles.

1. Photodynamic therapy of cancer: An update

2. Photodynamic therapy (PDT) of cancer: from local to systemic treatment

3. Mechanisms in photodynamic therapy: Part three—Photosensitizer pharmacokinetics, biodistribution, tumor localization and modes of tumor destruction

4. Photodynamic therapy and anti-tumour immunity

5. ICH, Guideline S9—Nonclinical Evaluation for Anticancer Pharmaceuticalshttp://122.3.253.116/attachments/article/99526/S9%20Step%204.pdf. URL

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Better in the Near Infrared: Sulfonamide Perfluorinated-Phenyl Photosensitizers for Improved Simultaneous Targeted Photodynamic Therapy and Real-Time Fluorescence Imaging;ACS Applied Materials & Interfaces;2024-09-14

2. Porphyrin Atropisomerism as a Molecular Engineering Tool in Medicinal Chemistry, Molecular Recognition, Supramolecular Assembly, and Catalysis;Chemistry – A European Journal;2024-07-10

3. Photodynamic therapy combined with immunotherapy: Recent advances and future research directions;Coordination Chemistry Reviews;2023-11

4. High reactive oxygen species produced from fluorescence carbon dots for anticancer and photodynamic therapies: A review;Luminescence;2022-10-17

5. Photodynamic inactivation (PDI) as a promising alternative to current pharmaceuticals for the treatment of resistant microorganisms;Recent Highlights II;2022